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Abstract
Because no effective methods for preventing or screening for ovarian cancer exist, symptom 
recognition is integral to its early detection. The Centers for Disease Control and Prevention’s 
Inside Knowledge: Get the Facts about Gynecologic Cancer campaign was developed to raise 
awareness and educate women and providers about risk factors, symptoms, recommended 
screening, and prevention strategies for the five main gynecologic cancers, including ovarian 
cancer. Inside Knowledge campaign materials were utilized by CDC’s National Comprehensive 
Cancer Control Program grantees to educate women and providers about gynecologic cancer from 
2014 to 2015. Grantees recruited participants and held educational sessions using Inside 
Knowledge materials. Questionnaires were given before and after the sessions to assess changes in 
awareness, confidence, and behavioral intentions around gynecologic cancer information and 
analyzed in 2016. This analysis focused on an assessment of changes related to ovarian cancer 
information. Participants’ knowledge increased after educational sessions. Among women, there 
were increases in correctly identifying that the Papanicolaou (Pap) test does not screen for ovarian 
cancer (89.2%) and that genetic testing is available (77.9%). There was a lower increase in 
knowledge that HPV is not a cause of ovarian cancer (56.4%). Providers and women reported 
significant increases in their confidence in their ability to talk to each other about gynecologic 
cancer post-session. Ovarian cancer awareness, confidence, and related behaviors increased in 
participants exposed to Inside Knowledge materials. Using these materials to increase knowledge 
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could lead to more empowered patients, better provider-patient communications, and improved 
care for gynecologic cancers, including ovarian cancer.
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Introduction
Ovarian cancer accounts for more deaths than any other gynecologic cancer, with 14,000 
women dying yearly [1, 2]. Due to an aging population, these numbers are expected to 
increase [3]. No screening tests are currently recommended for ovarian cancer [4]. Though 
specific symptoms are associated with ovarian cancer, they may appear non-specific if 
patients or providers are unaware of their association [5]. Consequently, ovarian cancer is 
usually diagnosed at a late stage after the cancer has spread, leading to a poor prognosis [6]. 
Because there are no effective methods for prevention or screening, symptom recognition is 
integral to early detection of ovarian cancer.
The Inside Knowledge: Get the Facts about Gynecologic Cancer campaign was developed 
by the Centers for Disease Control and Prevention (CDC), in collaboration with the 
Department of Health and Human Services’ Office on Women’s Health, to support the 
Gynecologic Cancer Education and Awareness Act of 2005 (Johanna’s Law) [7]. The 
campaign is designed to raise awareness of the five main types of gynecologic cancer 
(cervical, ovarian, uterine, vaginal, and vulvar) and educate women and providers about risk 
factors, symptoms, recommended screening, and prevention strategies for these cancers [7]. 
It encourages women to understand what is normal for themselves so they can recognize any 
persistent changes and seek timely medical care. Inside Knowledge resources include print, 
broadcast, and digital public service announcements; educational materials such as 
brochures and fact sheets; and continuing education modules for providers.
In this study, Inside Knowledge materials were utilized by National Comprehensive Cancer 
Control Program (NCCCP) grantees to educate women and providers in local US 
communities. The NCCCP is funded by CDC to develop state, tribal, or territorial-specific 
cancer plans containing evidence-based interventions for preventing and controlling cancer 
at the community level. Grantees are well-versed in the cancer-related needs of their 
populations and have demonstrated success in implementing public health efforts to decrease 
cancer incidence, morbidity, and mortality [8, 9]. Participant knowledge and behavioral 
intentions around ovarian cancer were assessed after participating in NCCCP educational 
sessions using Inside Knowledge materials. While Inside Knowledge addresses five types of 
gynecologic cancers, this study analysis focuses only on changes in ovarian cancer 
knowledge, attitudes, and behaviors among participants.
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Methods
Participants and Sessions
Participants included women aged 18 years and older and healthcare providers from eight 
NCCCP grantee areas: Alaska, Michigan, New Jersey, Puerto Rico, Tennessee, Texas, West 
Virginia, and Wisconsin in 2014 and 2015. Recruitment was carried out by grantees and 
included flyers, newspaper ads, email listservs, social media, and other communications 
advertising an educational session on gynecologic cancer.
Sessions were held in local areas determined by the grantee, to maximize participation 
and/or reach the most at need (those of low socioeconomic status or from traditionally 
underserved groups). Though recruitment methods varied somewhat and information 
presentation was specific to each population (i.e., educators/facilitators from local areas 
were used), each session followed a standardized pre-determined format, planned according 
to multiple learning theories including the health behavior model, the self-efficacy model, 
and the theory of planned behavior [10–12]. During sessions, grantees initially administered 
a questionnaire to establish baseline knowledge of messages in the Inside Knowledge 
campaign and participants’ experience with gynecologic cancer, including ovarian cancer. 
Trained facilitators conducted educational discussions of the Inside Knowledge materials 
including a print brochure, fact sheets, symptoms diary, and survivor stories. Following 
facilitated discussions, questionnaires were administered again to measure differences in 
knowledge and uptake of the information presented.
Training of all grantee-appointed facilitators was conducted in one interactive group session. 
Though the sessions were required to have the same format, facilitators were allowed to 
tailor discussions to their population for maximum impact (for instance, storytelling was 
used in Alaska sessions as opposed to a lecture format). Sessions were held in English, 
except in Puerto Rico, which used Spanish Inside Knowledge materials and conducted 
sessions in Spanish. All Inside Knowledge materials used were provided by CDC and are 
available to the public free upon request from the CDC website. Minimal incentives were 
provided for participants, consistent with federal government Office of Management and 
Budget (OMB) regulations, such as $30 gift cards for public participants and CME credits 
for providers.
Data Collection
The identical pre- and post-session questionnaires were designed to assess key Inside 
Knowledge campaign messages and controlled for participants’ prior knowledge. Public and 
provider questionnaires asked the same questions; however, in some cases, wording was 
slightly changed to ensure readability and comprehension. To maintain confidentiality, 
questionnaires were not linked to individual participants. Unique models of learning theory 
were used to develop the questionnaire. The health belief model, stating that health behavior 
is determined by personal beliefs about a disease including perceived (1) seriousness, (2) 
susceptibility, (3) benefits, and (4) barriers, was used to develop questions related to health 
beliefs, such as, “Please indicate how much you agree or disagree with the following 
statement: Women should be generally aware of gynecologic cancer signs and symptoms” 
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[10, 13]. The self-efficacy model, relating to a sense of control over one’s environment and 
behavior, was used to develop questions related to confidence in talking about health issues, 
such as “How confident are you that you have enough information to inform your patients 
about ovarian cancer?” [11]. The theory of planned behavior, stating that intention is the 
closest prediction of behavior, was used to develop questions related to behavioral 
intentions, such as “Please check the box which indicates how likely you are to ‘Talk to my 
doctor about genetic testing for BRCA1 and BRCA2 genes and other syndromes that can be 
inherited’” [12]. Information on participant demographics and providers’ clinical practice 
characteristics was also obtained.
Questions were closed-ended and included multiple choice, five-item Likert scale, and true/
false questions. Questionnaire usability testing was completed with women and providers 
prior to use in educational sessions. Paper questionnaires were entered into an electronic 
database using Snap Survey Software. Scanned surveys were reviewed by two researchers in 
order to correct data entry errors that occurred during the scanning process and ensure the 
quality of scanned data.
CDC determined that this study constituted public health practice and did not require 
Institutional Review Board (IRB) review. OMB reviewed and approved all data collection 
aspects of this study, including the questionnaires. Per OMB regulations, informed consent 
was obtained from all participants, and all questionnaires contained the OMB approval 
number 0920-0800.
Statistical Analysis
Dataset Preparation and Variables—Data analysis was performed in 2016. Prior to 
analysis, we examined the frequency counts and distribution of all variables. We collapsed 
categories for some demographic variables due to infrequent responses (e.g., age, education 
level, and race) to protect confidentiality. Participants selecting several or more races as their 
racial/ethnic background were coded as “multiple race/other.” For providers who specified 
“other” as their specialty, we created new specialty categories if enough similar responses 
were provided (e.g., pediatricians and school nurses). In some cases, participants provided 
more than one response to a question requiring only a single response. Some questions also 
allowed for more than one correct response. New dichotomous variables that indicated all 
correct responses versus partially or no correct responses were developed, as well as 
variables that recoded multiple responses to single response questions as missing. Because 
relatively few participants provided responses low on the Likert scales, behavioral intentions 
measured on a Likert scale were individually categorized as extremely likely/somewhat 
likely or not at all likely/not very likely/neither. Confidence levels also measured on a Likert 
scale were grouped as somewhat confident/extremely confident or neutral/not very 
confident/not at all confident.
Data Analysis—We examined the demographic characteristics of providers and women 
who attended the Inside Knowledge educational sessions. Because ovarian cancer was the 
focus of this analysis, we analyzed all survey questions specific to ovarian cancer (e.g., risk 
factors for ovarian cancer), and other questions that included ovarian cancer as a response 
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option (e.g., availability of genetic testing or an effective screening test). We also included 
questions about symptom recognition, confidence, and behavioral intentions for gynecologic 
cancer overall if they were relevant to ovarian cancer. In some instances, we only analyzed 
the response options that were relevant to ovarian cancer (e.g., symptoms consistent with 
ovarian cancer). For the healthcare provider analysis, we conducted bivariate analyses 
between obstetricians/gynecologists (OBGYNs) and all other providers (primary care 
physicians, family physicians, physician assistants, nurses, etc.) because OBGYNs have 
been shown to have a higher level of baseline gynecologic cancer knowledge [14]. We 
assessed pre- to post-test differences in knowledge of risk factors, symptoms, diagnosis, 
behavioral intentions, and level of confidence in discussing ovarian cancer among women 
and both groups of providers.
SAS 9.3 (SAS Institute, Inc.; Cary, NC) was used to conduct all analyses. All statistical tests 
used a significance level set at alpha = 0.05, and p values were obtained from Chi-square 
tests or Fisher’s exact test for categorical variables.
Results
Table 1 shows the case characteristics of all participants. Most public participants were 45 
years old or older (67.4%) and were most commonly white (40.8%) and Hispanic/Latino 
(37.2%). The majority of provider participants were between 45 and 64 years old (52.5% of 
obstetrician/gynecologists and 57.1% of other specialties). Most obstetrician/gynecologist 
providers were male (59.1%) and most providers with other specialties were female 
(90.9%). There were 90.4% of obstetrician/gynecologists who were Hispanic/Latino, and 
58.4% of other providers were white. Most obstetrician/gynecologist providers saw a 
combination of inpatients and outpatients (68%) and saw 21–30 patients per day (35.9%). 
Relatively few providers were aware of the Inside Knowledge campaign (10% of 
obstetrician/gynecologists and 6.9% of other specialties), but providers agreed that 
gynecologic cancer was a problem in their patient population (93.3% of obstetrician/
gynecologists and 80.9% of other specialties). (Table 1)
Table 2 shows knowledge changes among participants after facilitated discussions of Inside 
Knowledge materials. Significant increases in risk factor knowledge were seen in both 
public and providers after educational sessions. Increases were seen for all participants post-
session for correctly identifying never having given birth or infertility as a risk factor for 
ovarian cancer (73.6% of obstetrician/gynecologists, 77.8% of other specialty providers, and 
78.1% of public participants). Public participants and providers with specialties other than 
obstetrician/gynecologists saw significant increases in knowledge of Ashkenazi Jewish 
background as a risk factor for ovarian cancer (65.9% of other specialty providers and 
76.6% of public participants) and in correctly identifying all risk factors for ovarian cancer 
(50.0% of other specialty providers and 43.8 of public participants). After sessions, 23.1% 
of obstetrician/gynecologists correctly identified all risk factors for ovarian cancer. No 
significant increases were seen for family history as a risk factor, but presession knowledge 
of this risk factor was high in all participants.
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Public participants showed a significant increase in post-session knowledge of pelvic pain/
pressure (89.4%), abdominal or back pain (86.7%), bloating (87.1%), and changes in 
bathroom habits (83.9%) as symptoms of ovarian cancer (Table 2). Providers of other 
specialties also showed significant increases in post-session knowledge of pelvic pain/
pressure (88.5%) and abnormal bleeding (51.6%) as symptoms of ovarian cancer. No 
significant increases in symptom knowledge were seen in obstetri- cian/gynecologists, with 
93.3% correctly identifying pelvic pain/pressure and 25.8% correctly identifying abnormal 
bleeding or discharge as symptoms of ovarian cancer.
Figure 1 shows changes in knowledge of ovarian cancer testing and diagnostics after 
facilitated discussions of Inside Knowledge materials. There was a significant increase 
among public participants in correctly identifying that the Pap test does not screen for 
ovarian cancer (89.2%) and that genetic testing is available for ovarian cancer (77.9%). 
However, fewer public participants also correctly identified that HPV is not a cause of 
ovarian cancer after sessions (56.4%) than prior (68.1%). No significant changes were seen 
in provider knowledge for Pap testing, HPV, and genetic testing as they relate to ovarian 
cancer, but correct knowledge was high for all provider participants both before and after 
sessions, ranging from 92.1 to 96.6% for obstetrician/gynecologists and 83.1 to 98.4% for 
other specialties post-session.
Table 3 shows provider behavioral intentions and confidence with ovarian cancer 
information before and after facilitated discussions of Inside Knowledge materials. All 
providers reported a significant increase in confidence with their ability to inform patients 
about ovarian cancer (97.8% of obstetrician/gynecologists and 91.0% of other specialties). 
Providers with other specialties also saw significant increases in their confidence to educate 
their patients appropriately about gynecologic cancer risks and symptoms (91.8%) and to 
assess symptoms of gynecologic cancer in their patients and conduct appropriate tests 
(85.8%). These providers also reported a significant increase after sessions in their intention 
to refer patients whom they suspected of having a gynecologic cancer to gynecologic 
oncologist. No other significant increases were seen in obstetrician/gynecologists, but post-
session agreement ranged from 88.5 to 97.8% for items assessed in this group.
Table 3 also shows public behavioral intentions and confidence with talking to their 
providers, friends, and family about ovarian cancer information before and after facilitated 
discussions of Inside Knowledge materials. After sessions, public participants reported 
significant increases in their confidence surrounding talking to their providers and family 
about gynecologic cancer, including their ability to talk to their doctor about genetic testing 
(69.8% agreement), talk about gynecologic cancer with their family (84.5% agreement), and 
talk about gynecologic cancer with their friends (84.2% agreement). Public participants also 
reported significant increases in their intentions to bring up gynecologic cancer the next time 
they visit their healthcare provider (87.4% agreement), look for more information on 
gynecologic cancer (86.9% agreement), talk to their doctor about gynecologic cancer 
(90.3%), and talk to their doctor about symptoms they may be having (86.6%).
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Discussion
After facilitated discussions of Inside Knowledge materials, correct knowledge of ovarian 
cancer information increased for participants. Women were more confident with their ability 
to talk to their providers about gynecologic cancer and expressed positive intentions about 
discussing gynecologic cancer with families, friends, and doctors after participation. For 
several survey items, we found significant differences in knowledge across sites for both 
public and provider sessions. Women attending sessions in Wisconsin and Tennessee and 
providers in Puerto Rico and New Jersey tended to score lower on knowledge questions. For 
example, providers and women in Wisconsin and Puerto Rico were less aware that women 
with Ashkenazi Jewish ancestry are at increased risk for ovarian cancer. Additionally, similar 
to previous studies, obstetrician/gynecologists had higher baseline knowledge of ovarian 
cancer, but knowledge increased among all provider groups after facilitated discussions [15].
The Inside Knowledge campaign is the only campaign related to ovarian cancer that is 
national in scope, and its web site is consistently the most visited CDC cancer site, 
suggesting the need for gynecologic cancer information. In 2015 alone, these webpages 
received 3,732,892 visits [15]. Because of the need for this information, the campaign is 
currently ongoing, with media advertisements and information available to the public on the 
campaign website. Public health campaigns like Inside Knowledge are considered to be an 
effective tool by The Guide to Community Preventive Services. Many past campaigns have 
been used to improve awareness or promote healthy behaviors for a variety of diseases [16]. 
A campaign to increase awareness of symptoms associated with acute HIV infection 
utilizing symptom cards, print media, and targeted billboard advertising increased HIV 
symptom recognition [17]. Similar strategies are also being used to increase testing for 
hepatitis C in people born between 1945 and 1965 [18]. Antismoking campaigns using 
television advertising, such as the National Truth Campaign and CDC’s Tips from Former 
Smokers, have resulted in decreased smoking initiation, increased quit attempts [19, 20]. 
CDC’s Screen for Life: National Colorectal Cancer Action Campaign and the African 
American Women and Mass Media campaign to promote breast cancer screening are 
additional examples of where multimedia efforts have been used successfully to promote 
knowledge and behavior change [21, 22]. Similarly, this evaluation points to the success of 
the Inside Knowledge campaign to increase knowledge of ovarian cancer information.
Some findings point to the need to reinforce certain messages in the Inside Knowledge 
campaign, including clarifying the types of cancers that are HPV-associated, emphasizing 
abnormal bleeding as a symptom, and Ashkenazi Jewish heritage as a risk factor for ovarian 
cancer. In particular, even though obstetrician/gynecologists had increased baseline ovarian 
cancer knowledge, many failed to identify abnormal bleeding as a symptom, indicating that 
even this group could benefit from improved educational materials. While campaign 
messages likely will evolve over time, our study found overall that current Inside Knowledge 
materials are effective at increasing knowledge among providers and their patients.
Since there are no effective prevention or early detection methods for ovarian cancer, 
education may help affect cancer incidence and mortality. Further, there is a wider call for 
community and clinical practice linkages, and utilization of Inside Knowledge materials by 
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the public and providers helps build these much needed linkages for ovarian cancer [23]. 
Because these materials are available on the Internet, free to download and print or order in 
hard copy, providers can have them in their offices and disseminate them to patients.
The knowledge gained from education on this topic can empower women to take greater 
control of their health and allow them to be more engaged patients, which can lead to 
improved self-management of their care and improve the relationship with their providers 
[24]. Providers can use this information to inform how they interact with patients on the 
topic of ovarian cancer and share the materials with their patients. These are important steps 
towards improving ovarian cancer awareness and related positive behaviors, such as women 
recognizing ovarian cancer symptoms and proactively seeking medical care. NCCCP 
grantees can also address ovarian cancer through additional avenues, such as collaborating 
with cancer control partners, developing position papers, promoting use of family history to 
identify those at increased risk, and encouraging referrals to gynecologic oncologists for 
specialized care.
Our analysis was subject to several limitations. For brevity, providers were only asked about 
the two most common symptoms of ovarian cancer, limiting our assessment of changes in 
their understanding of symptoms. Social desirability bias could also have affected answers 
of all participants to questions related to their behavioral intentions and confidence, causing 
them to overstate their agreement with statements presented. Finally, missing data varied 
among grantee datasets, potentially biasing our results if non-respondents would have 
answered items differently than respondents who answered all survey items. Study strengths 
include its design according to standard knowledge/behavioral theories, the inclusion of 
women from all races, including Asian/Pacific Islander and American Indian/Alaska Native 
from diverse areas of the United States, and the innovative and unique use of NCCCP (those 
engaged in the community) to identify and recruit participants to the sessions.
Conclusions
Ovarian cancer awareness, provider confidence in talking to patients about ovarian cancer, 
and confidence of women in talking to providers, family, and friends about gynecologic 
cancer, and related behaviors increased in women and providers using Inside Knowledge 
campaign materials. Using Inside Knowledge materials to increase knowledge could 
ultimately lead to more empowered patients, better providerpatient communications, and 
ultimately earlier diagnosis and improved care for ovarian cancer.
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Fig. 1. 
Knowledge of ovarian cancer testing and diagnostics among women and providers. Bars 
represent the percentage of each group (obstetricians/gynecologists, providers with other 
specialties, and public participants) that correctly that HPV is not a cause of ovarian cancer 
(blue bar), the Pap test does not screen for ovarian cancer (red bar), and genetic testing is 
available for ovarian cancer (green bar)
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Table 1
Characteristics of women and provider participants
Providers Public, n = 499
Obstetrician-
gynecologist, n = 106
Other specialty, n = 
259
N (%) N (%) P value N (%)
Age*
 <35 years 15 (14.6) 51 (20.1) 0.0002 87 (18.0)
 35–44 years 13 (12.6) 46 (18.1) 71 (14.7)
 45–54 years 25 (24.3) 70 (27.6) 105 (21.7)
 55–64 years 29 (28.2) 75 (29.5) 113 (23.4)
 65+ years 21 (20.4) 12 (4.7) 108 (22.3)
Gender*
 Male 62 (59.1) 23 (9.1) <.0001 N/A
 Female 43 (41.0) 229 (90.9)
Race/ethnicity*a
 Hispanic/Latino 94 (90.4) 53 (20.6) <.0001 177 (37.2)
 American Indian/Alaska Native – – 16 (3.4)
 Asian/Native Hawaiian/Pacific Islander 1 (1.0) 25 (9.7) 9 (1.9)
 African-American 1 (1.0) 24 (9.3) 70 (14.7)
 White/Caucasian 8 (7.7) 150 (58.4) 194 (40.8)
 Multiple race/other 0 (0) 5 (2.0) 10 (2.1)
 Specialty
 Family N/A 30 (11.6) <.0001 N/A
 Internal N/A 16 (6.2)
 Pediatrics N/A 3 (1.2)
 General medicine N/A 10 (3.9)
 OBGYN 106 (100) N/A
 Nurse practitioner/physician’s assistant N/A 43 (16.6)
 Nurse N/A 107 (41.3)
 School nurse N/A 9 (3.5)
 Other N/A 41 (15.8)
Work environment*
 Inpatient 2 (1.9) 22 (8.9) <.0001 N/A
 Outpatient 29 (28.2) 125 (50.8)
 Combination (inpatient/outpatient) 70 (68.0) 42 (17.1)
 School 0 27 (11.0)
 Other 2 (1.9) 30 (12.2)
Average patients seen per day*
 <10 7 (6.8) 58 (24.0) <.0001 N/A
 10–20 32 (31.1) 84 (34.7)
 21–30 37 (35.9) 46 (19.0)
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Providers Public, n = 499
Obstetrician-
gynecologist, n = 106
Other specialty, n = 
259
N (%) N (%) P value N (%)
 31–40 21 (20.4) 24 (9.9)
 41+ 5 (4.9) 19 (7.9)
 Not sure 1 (1.0) 11 (4.6)
 Some high school or less N/A 22 (4.7)
 High school graduate/GED 68 (14.6)
 Some college 126 (27.0)
 College graduate 94 (20.2)
 Graduate studies 147 (31.6)
 Other 9 (1.9)
Awareness of IK campaign 10 (10.0) 17 (6.9) 0.4340 93 (19.9)
Gynecologic cancer is a problem for my patient population 
(pre-session agreement)
98 (93.3) 203 (80.9) N/A
*p < 0.05 from Chi-square tests (providers only)
a
Race variables and Hispanic ethnicity were not mutually exclusive
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